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Abstract. The metastatic spread of tumor cells occurs
through a complex series of events, one of which in-
volves the adhesion of tumor cells to extracellular ma-
trix (ECM) components. Multiple interactions between
cell surface receptors of an adherent tumor cell and
the surrounding ECM contribute to cell motility and
invasion. The current studies evaluate the role of a cell
surface chondroitin sulfate proteoglycan (CSPG) in the
adhesion, motility, and invasive behavior of a highly
metastatic mouse melanoma cell line (K1735 M4) on
type I collagen matrices. By blocking mouse melanoma
cell production of CSPG with p-nitrophenyl ß-D-xylo-
pyranoside (ß-D-xyloside), a compound that uncouples
chondroitin sulfate from CSPG core protein synthesis,
we observed a corresponding decrease in melanoma
cell motility on type I collagen and invasive behavior
into type I collagen gels. Melanoma cell motility on
type I collagen could also be inhibited by removing
cell surface chondroitin sulfate with chondroitinase. In
contrast, type I collagen-mediated melanoma cell
T
UMOR cell metastasis involves a complex series of
interdependent events, oneofwhichinvolvestheadhe-
sion of tumor cells to extracellular matrix (ECM)'
components (Liotta et al., 1983). Although traditionally
considered as structural elements ofthe ECM, itis now ap-
preciated that various collagen types promote the adhesion
and migration ofnormal and transformed cells (Aumailley
and Timpl, 1986; Rubin et al., 1981; Dedhar et al., 1987;
Herbst et al., 1988; Chelberg et al., 1989). Additionally,
certain collagen types have been shown to promote direc-
tional motility ofnormal andtransformed cells, thus, poten-
tially contributing to the invasive process (Herbst et al.,
1988, Chelberg et al., 1989). The motility of normal and
transformed cellsmaybedirected byanadhesive gradient of
1. Abbreviations used in this paper: CSPG, chondroitin sulfate proteogly-
can; ECM, extracellular matrix; HSPG, heparan sulfate proteoglycan; PG,
proteoglycan.
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adhesion and spreading were not affected by either
ß-D-xyloside or chondroitinase treatments. These
results suggest that mouse melanoma CSPG is not a
primary cell adhesion receptor, but may play a role in
melanoma cell motility and invasion at the level of
cellular translocation. Furthermore, purified mouse
melanoma cell surface CSPG was shown, by affinity
chromatography and in solid phase binding assays, to
bind to type I collagen and this interaction was shown
to be mediated, at least in part, by chondroitin sulfate.
Additionally we have determined that mouse melanoma
CSPG is composed of a 11041) core protein that is
recognized by anti-CD44 antibodies on Western blots.
Collectively, our data suggests that interactions between
a cell surface CD44-related CSPG and type I collagen
in the ECM may play an important role in mouse mela-
noma cell motility and invasion, and that the chon-
droitin sulfate portion of the proteoglycan seems to be
a critical component in mediating this effect.
substratum-bound attractant,andthisprocessistermed hap-
totaxis (McCarthy and Furcht, 1984).
Tumor cells adhere and move on ECM components via
multiplecell surface receptors that interactwith distinct do-
mains on ECM proteins. Inadditionto thewell knowninte-
grin receptor model for cell-ECM interactions (Buck and
Horwitz, 1987, Hynes, 1987, Ruoslahti, 1988), substantial
evidence suggests an important role for cell surface pro-
teoglycans (PGs) inmediatingcelladhesion toECMcompo-
nents (Hooketal., 1984; Couchman andHook, 1988; Ruos-
lahti, 1988; Wight, 1989). Bothcell surfaceheparan sulfate
proteoglycans(HSPG) andchondroitinsulfateproteoglycans
(CSPG) have been implicated in modulating cell adhesion
(Larketal., 1985), buteach hasdistinct effectsoncell adhe-
sion (Ruoslahti, 1988, Gallagher, 1989). While cell surface
HSPG has been associated with the formation of tight cell
adhesion contacts on ECM components (Lark et al., 1985;
521Woods et al., 1986), cell surface CSPG has been implicated
in weakening cell adhesion (Lark et al., 1985, Culp et al.,
1978). Although the molecular mechanism by which CSPG
disrupts cell adhesion is not understood, CSPG may facili-
tate cell detachment from the ECM, and thereby promote tu-
mor cell motility and subsequent invasion.
To further evaluate the potential role ofcell surface CSPG
in tumor cell motility and invasion, we studied the effect of
p-nitrophenyl ß-D-xylopyranoside (ß-D-xyloside), an agent
than uncouples chondroitin sulfate addition to the protein
core (Schwartz, 1977), on the invasion of melanoma cells
into type I collagen gels. Others have shown that the inhibi-
tion of CSPG synthesis by ß-D-xyloside causes a dose-
dependent inhibition of invasive morphogenetic events such
as the branching of salivary glands (Thompson and Spooner,
1982) and ureteric buds (Klein et al., 1989) . Our studies
show that O-D-xyloside inhibits the invasion of mouse mela-
noma cells into type I collagen gels, suggesting a role for cell
surface CSPG in contributing to the invasive behavior of
these cells. Similarly, haptotactic motility of melanoma cells
on type I collagen was inhibited by either ß-D-xyloside or
chondroitinase pretreatment. However, type I collagen-me-
diated melanoma cell adhesion or spreading was not af-
fected by these treatments. These data suggest that while
melanoma CSPG may be important in cell motility at the
level of translocation, it is apparently not a primary cell ad-
hesion receptor. We have isolated andpartially characterized
a cell surface CSPG from mouse melanoma cells that inter-
acts with type I collagen of the ECM and has properties con-
sistent with localization as an integral membrane compo-
nent. Furthermore, our data indicates that the 110-kD core
protein of mouse melanoma CSPG is immunologically re-
lated to the CD44 antigen, implicated in several aspects of
cell-cell and cell-ECM interactions (Gallatin et al., 1989 ;
Haynes et al., 1989; Jalkanen et al., 1986; Miyake et al. :
1990) and most recently implicated in mediating the meta-
static behavior of certain carcinoma cell lines (Giinthert et
al., 1991). Thus, mouse melanoma cells express a cell sur-
face CD44-related CSPG molecule that may play an impor-
tant role in collagen-mediated melanoma cell motility and
invasion.
Materials andMethods
Cell Culture
A highly metastatic clone (M4) ofthe K1735 mouse melanoma, was gener-
ously provided by Dr. I. J. Fidler (M.D. Anderson Hospital Cancer Center,
Houston, TX). This melanoma cell line was maintained by in vitro culture
in DMEM (Sigma Chemical Co., St. Louis, MO) supplemented with 10%
heat-inactivated calf serum (Sigma Chemical Co.). The number of in vitro
passages was limited to eight in order to minimize phenotypic drift. There
was nodetectablechange in the metastaticphenotype ofthese cells overthis
time, as measured by an experimental metastasis assay (McCarthy et al.,
1988b) .
Invasion Gels
Gels composed of type I collagen were prepared under sterile conditions
using a modified protocol as described by Shor (1980). Type I collagen
(Collagen Corp., Palo Alto, CA; 3.3 mg/ml Vitrogen in 0.013 M HCl) was
mixedtoafinal concentration of2.2 mg/ml in DMEM (Dulbecco's modified
Eagle's medium; Sigma Chemical Co.), 10% PBS (vol/vol), and 0.225%
NaHC03 (wt/vol). Reagents were stored at 4°C to prevent premature fibril
assembly. Aliquots of 1.5 ml ofthis solution were added to each well of a
6-well plate (total areaper well of9.6 cm2; Costar, Cambridge, MA), care-
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fully swirled to allow uniform distribution and allowed to solidify for 1 h
at 37°C. The gels were overlaid with 2 ml DMEM (pH 7.4) overnight, then
reequilibrated with fresh DMEM for 4 additional hours the next morning.
Confluent cells were harvested with trypsin (0.25%)/EDTA (1 mM),
pelleted by centrifugation (1,500 rpm, 5 min) and resuspended in DMEM
containing 2.5% heat-inactivated calf serum. The DMEM used to equili-
brate the gels was removed and a 2-ml cell suspension containing 5 x 10°
cells was added to the top of the gels. The plates were swirled gently to
obtain an even distribution of cells on the gel surfaceand incubated at 37°C
in a humidified, 5 % C02 incubator.
Cell invasion was measured after 48-72 h using an inverted phase-
contrast microscope (Nikon Diaphot) equipped with a calibrated fine focus
knob, at 200x magnification. The fine focus knob was calibrated using a
collagen gel sandwiched betweentwocoverslip-separated glass slides toac-
count for the refractive properties of the gel. The number of invading cells
was determined at successive 20-km (1 cell diameter) intervals in five ran-
domly selected fields. Quantitation was made at increasing depths within
the gels until no additional cells were detected. The total number of cells
detected in five fields at a particular level was multiplied by a constant
(65.36) to obtain the number of cells at each interval per cm2 ofgel area.
Data are presented as the total number of cells penetrating the gel per cm2
of surface area, calculated by totaling the number of cells per cm2 at suc-
cessive levels. Results are reported as means, plus or minus standard errors
of the means, of duplicate gels.
CellMigration, Adhesion, andSpreadingAssays
Cell motilitywas assayedin 48-wellmicrochambers (Neuroprobe, Bethesda,
MD), utilizing 8-Am pore size polyvinyl pyrrolidone-free polycarbonate fil-
ters (Nucleopore, Pleasanton, CA) . The undersides of the filters were pre-
coatedwith eithertype I collagen or fibronectin at 1 ug/ml (a concentration
chosenon the basis of halfmaximal migration promoting activity ofthe pro-
teins), as described previously (McCarthy et al., 1986; Chelberg et al.,
1989). The lower wells of the Boyden chambers were filled with DMEM
supplemented with 20 mM Hepes, 5 mg/nil BSA . Cells were released with
5 mM EDTA in HBSS (Ca,Mg free), washed and resuspended to a final
concentration of 4 x 105 cells/ml in DMEM, 20 mM Hepes, 5 mg/ml
BSA. Cells were added to the upper wells at 2 x 10° cells/well and migra-
tion to the underside ofthe precoated filter was measured after4 h at 37°C.
Cell adhesion to protein-coated substrata was performed as described
previously (McCarthy et al., 1986; Chelberg et al., 1989) using 1 mg/ml
type I collagen or fibronectin. Briefly, for the adhesion assays, cell cultures
were radiolabeled for the final 18 h with 2 ACi/ml 3H-thymidine, released
with 5 mM EDTA in HBSS, washed, and resuspended to a final concentra-
tion of 5 x 10° cells/ml in adhesion medium (DMEM supplemented with
20 mM Hepes, 5 mg/ml BSA [fatty acid free; Sigma Chemical Co.]). Ap-
proximately 5 x 103 cells/well were added in 100 Al of adhesion medium
and allowed to adhere to protein coated substrata for 45 min. After gentle
washing (4x) adherent cells were solubilized in 150 'al of 0.5N NaOH con-
taining 1% SDS, and radioactivity was quantitated with a Beckman LS 3801
liquid scintillation counter.
Measurement ofcell spreading was performed as described (Chelberg et
al., 1989) by measuring the area of cells plated onto protein-coated sub-
strata. Briefly, cells prepared as described above were incubated in 24-well
tissue culture plates (Costar) coated with fibronectin or type I collagen for
90 min, and then fixed by the addition of PBS containing 1-2% glutaralde-
hyde at 37°C. The cells were stained by the addition ofa 0.5% solution of
Coomassie R-250 stain in 95% ethanol. Cells were viewed on a Nikon Dia-
phot inverted phase microscope connected to an Optomax System IV image
analysis system integrated with an Apple Ile computer. Cell area was deter-
mined for at least 30 randomly selected cells per culture, and each ex-
perimental condition was performed in duplicate.
ß-DXyloside andChondroitinaseABCPretreatment
For the invasion assays, cells were seeded onto the gels as described above
in the presence of 0, 0.05, 0.1, 0.5 or 1.0 mM p-nitrophenyl-ß-D-
xylopyranoside [ß-D-xyloside] (Sigma Chemical Co.) or p-nitrophenyl-a-
D-xylopyranoside [a-D-xyloside] (Koch-Light Ltd., Suffolk, England). For
motility, adhesion and spreading assays, or before proteoglycan extraction,
cells were exposed to O-D-xyloside for 48 h to inhibit CSPG synthesis by
replacing the medium ofcell cultures, at 50 % confluency, withDMEM con-
taining 2.5% heat-inactivated calf serum, with or without 1 MM 0-D-xylo-
side. a-D-xyloside does not inhibit CSPG synthesis and was used as a con-
trol in invasion and motility assays. 1 mM a or O-D-xyloside was also
included in the medium during the assays. O-D-xyloside was also added to
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the cells were exposed to the drug for a total of 48 h (see below). Levels
of protein synthesis were examined for cells pretreated (or not) with ß-D-
xyloside. Briefly, cells grown in 96-well plates (Costar, Cambridge MA)
were exposed (or not) to 1.0 mM ß-D-xyloside for 48 h and 5 juCi/ml
3H-leucine was added to each of triplicate wells for the final 6 h. Levels
of 3H-leucine incorporation into cell-associated proteins were determined
by harvesting cells with a Brandell cell harvester (Gaithersburg, MD), and
the values were compared for cells exposed (or not) to ß-D-xyloside on a
per cell basis. Thelattervalue was obtained by counting cells/well (in tripli-
cate), or determining relative DNA synthesis (0.2 uCi/p1 3H-thymidine la-
bel added for final 18 h). Radioactivity was quantitated by liquid scintilla-
tion spectroscopy (Beckman LS 3801).
For chondroitinase ABC treatment, cells were pretreated for 15 min with
0.1 U/ml chondroitinase ABC (Sigma Chemical Co.) before motility and
adhesion assays, as described by Saunders and Bernfield (1988). Chon-
droitinase ABC enzyme (0.1 U/ml) was also included in the cell medium
during migration and adhesionassays. Theabsence ofproteases in thechon-
droitinase ABC enzyme was verified by alack ofdigestionofazocaseinafter
a 60-min incubation with the enzyme at 37°C (Tomarelli et al., 1949).
Chondroitinase ABC enzyme activity was verified for the assay conditions
used, under conditions of Saito et al. (1968).
Proteoglycan Extraction
Prior to extraction, melanoma cell proteoglycans (PGs) were preferentially
labeled with 35S-sulfate for 18 h by replacing the medium in 80% confluent
cultures with RPMI 1640 containing 0.1 mM Na2SO4, 0.36 mM gluta-
mine, and 50 jXi/ml Na235SO4 (Carrier free, Specific Activity 43 Ci/mg;
ICN Biomedicals, Irvine, CA). An extraction protocol utilizing detergent-
mediated cell lysis was followed to specifically enrich for intact plasma
membrane-associatedPG (Yanagashitaetal., 1987) . To removeperipheral,
extrinsically associated PG, the medium of 35S-labeled cell cultures was
replaced with 30ml DMEM containing50 jAg/mlheparin for a 30-min incu-
bation at 18°C (Yanagashita and Hascall, 1984). The heparin extract was
removed and 30 ml cellular extraction buffer (0.15 M NaCl, 10 mM Tris,
5 MM MgC12, 2 mM EDTA, 0.25 mM DTT, 1 mM PMSF, 1% Triton
X-100, pH 7.2) was added to each roller bottle and incubated in a rolling
apparatus at 37°C for 15 min (Carey and Todd, 1986). The cellular extracts,
containing plasma membrane-associated and intracellular PG, were cen-
trifuged at 1,500rpm for 5 min to removeinsoluble material. The remaining
extracellular matrix-cytoskeletal-associated PG were solubilized in 4 M
guanidine containing 50 mM NaAcetate, pH 5.8, 2% Triton X-100, 10 mM
EDTA, 1 mg/ml benzamidine, 0.1 M 6-aminohexanoic acid, for a 30-min
incubation at 25°C (Oegema et al., 1979). All extracts were dialyzed in
small pore dialysis tubing (mol wt cut off 3,500) against successive changes
of 0.5 M NaAcetate, pH 6.8, 0.1 M NaSulfate containing 10 mM EDTA,
0.1 mM PMSF, 10 mM 6-aminohexanoic acid (Oegema et al., 1979) until
no radioactivity was observed in the dialysis buffer.
Purification ofDetergent-extracted CSPG
Detergent-extracted 35S-PGs were dialyzed into DEAE buffer (0.15 M
Tris, 6.0 M Urea, 0.1 M NaCl, 0.01 M EDTA, 0.01 M 6-aminohexanoicacid,
0.2% Triton X-100, 0.1 mM PMSF, pH 7.0), and purified by HPLC (Beck-
man Model 110 A) with a 7.5 x 75 mm TSK DEAE 5PW anion exchange
column (BioRad Laboratories, Richmond, CA) using a linear salt gradient
from 0.1 to 0.8 M NaCl over a 45-min period as described (Klein et al.,
1989) . The salt gradient was monitored by conductivity measurements
using a Radiometer Conductivity Meter (model CDM 83). Comparisons
were made to standards of known NaCl concentration in DEAE buffer to
calculate the actual salt concentrations ofthe fractions. To insure adequate
separation of 35S-PG, HPLC-DEAE chromatographic peaks were each
rechromatographed on the same column before further characterization.
Recovery of radioactivity from the HPLC-DEAE columns was 90-95% .
Before iodination, DEAE-HPLC-separated CSPG was further purified
on Sepharose CL-4B (Sigma Chemical Co.) columns equilibrated and
eluted with 0.05 M sodium acetate, pH 7.0, containing 4 M guanidine, 1%
Triton X-100, and 0.04% sodium azide at a flow rate of 3 ml/h (Klein et
al., 1986). Fractions of 1.0-2.0 ml were collected with an 85-95% recovery
of radioactivity. Rat chondrosarcoma chondroitin sulfate PGs (Oegema et
al., 1975) associated with 4% hyaluronic acid and glucuronolactone were
used to mark the column void (V.) and total (V,) volumes, respectively.
CSPG core protein was labeled with 2.5 mCi 1251 on Iodobeads (Pierce
Chemical Co., Rockford, IL) in 0.05 M Tris, pH 7, 0.5% CHAPS. 125I-
CSPG was bound to DEAE-Spetra/Gel M (Spectrum, Los Angeles, CA),
washed with DEAE buffer (see above) to remove unbound 1251, eluted with
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DEAE buffercontaining 1.0 M NaCl, and dialyzed extensively in deionized
water, 1 MM PMSF. Radioactivity per sample was quantitated by gamma
ray scintillation (TM Analytic, Gamma Trac 1193). To visualize CSPGcore
protein by autoradiography, 1251-CSPG was digested with chondroitinase
ABC (Seikagaku America Inc., Rockville, MD) and analyzed by 6-15%
SDS gel electrophoresis under nonreducing conditions (McCarthy et al.,
1988x) . Gels were dried under vacuum andused for autoradiography using
Kodak XAR5.
Characterization ofDetergent-extracted CSPG
The hydrodynamic properties of detergent-extracted 35S-PG and 35S-
glycosaminoglycans (GAGs) were evaluated by gel filtration on 0.9 x 110
cm Sepharose CL-6B (Sigma Chemical Co.) columns. The columns were
equilibrated andeluted with0.5 M sodium acetate, pH 7.0, containing0.2%
CHAPS, at a flow rate of 3 ml/h (Klein et al., 1986). 35S-GAGS were re-
leased from PG protein cores by alkaline borohydride reduction, neutral-
ized, and desalted on Sephadex G-50 (Sigma Chemical Co.) columns, as
previously described (Oegema et al., 1979). 35S-GAGs were recovered
from the column Vo with <5% of alkali-released material included in the
column. The heparan sulfate and chondroitin sulfate content of 35S-GAG
samples were determined by sequential nitrous acid deaminative cleavage
and chondroitinase ABC treatment, respectively, as previously described
(Brown et al., 1981). The hydrodynamic properties of 35S-chondroitin/der-
matan sulfate recovered after nitrous acid treatment were determined on
Sepharose CL-6B columns. The C4:6 ratio of oligosaccharides generated
by chondroitinase ABC digestion was determined by descending paper
chromatography using C4, C6, and unsulfated oligosaccharide standards
(Saito et al., 1968). The absence of iduronic acid residues within these
chains was confirmed by equivalent sensitivity ofchondroitin/dermatan sul-
fate to chondroitinase ABC (Sigma Chemical Co.), which digests chondroi-
tin sulfate and dermatan sulfate and chondroitinase AC II (Sigma Chemical
Co.), which digests only chondroitin sulfate. Detergent-extracted 35S-macro-
molecules resistant to the effects of nitrous acid and chondroitinase ABC
digestion were considered "35S-glycoproteine (Brown et al ., 1981), and
this population never exceeded 10% of any extract examined.
7ype I Collagen Afnity Chromatography and
Binding Assays
For affinity chromatography, typeI collagen (Vitrogen) was covalently cou-
pled to Reacti-Gel according to manufacturers instructions (Pierce Chemi-
cal Co.). Final concentration bound was 0.175 mg type I collagen/ml gel.
Columns (30 ml bed volume) were equilibrated with 50 mM Tris, pH 6.8,
0.5% CHAPS, 0.05 M NaCl, 0.01 M 6-amino hexanoic acid, 0.1 mM PMSF,
1.0 mM NEM, and 0.02% azide. Detergent-extracted 35S-CSPG was ap-
plied to the columns, washed with three column volumes of buffer and
eluted with a saltgradient from 0.05 to 1.0 M NaCl. To assure that the bind-
ing of CSPG was specific to type I collagen, 35S-CSPG was applied to
duplicate columns prepared without type Icollagen. Recovery ofradioactiv-
ity from these columns was 90-95%.
Solid phase binding assays were performed with Immulon 1 plates as a
support (Skubitz et al., 1988). The substrata were prepared, as in the adhe-
sion assays, by coating the surface of the wells with intact type I collagen
(0.2 pg/well) or BSA (0.2 gg/well; fatty acid free; Sigma Chemical Co.).
The plates were blocked for 1 h with 0.1 M carbonate buffer (Engvall and
Perlmann, 1972) containing 5 mg/ml BSA, then washed 5 x with deionized
water, and 35S-CSPG was added to the wells in binding buffer (50 mM
Tris, pH 6.8, 50 mM NaCl, 5 mg/ml BSA). The plates were incubated for
2 h at 37°C, washed (x5) with binding buffer, and the bound 35S-CSPG
was solubilized with 0.5 N NaOH containing 1% SDS.
Octyl Sepharose Chromatography
Detergent-extracted 35S-CSPG, purified by ion exchange chromatography,
was resuspended in Octyl Sepharose buffer (4.0 M Guanidine HCl, 20 mM
Tris, pH 6.8). Samples were applied to a 5-ml Octyl Sepharose CL-4B
(Sigma Chemical Co.) column at a flow rate of 0.5 nil/min. Hydrophobic
CSPG were then eluted with a linear gradient of 0 to 0.5% Triton X-100
in Octyl Sepharose buffer (Yanagashita et al., 1987). 2 ml-fractions were
analyzed for 35S-radioactivity and percent Triton X-100 by absorbance at
280 run.
Immunoblots
For identificationofCSPG core protein by immunoblot, detergent-extracted
523Figure 1. /3-D-xyloside inhibits melanoma cell invasion into type I
collagen gels . Native type I collagen gels were prepared (2 .2 mg/nd
final concentration) as described in Materials and Methods . (A)
Shown are the invasion profiles for mouse melanoma cells plated
on the surface ofgels in the absence (solid bars) or presence of 1 .0
MM a-D-xyloside (cross hatched bars) or 1 .0 MM ß-D-xyloside
(dotted bars) . (B) The total number of cells invading these gels in
the presence (or absence) of indicated concentrations of ß-D-
xyloside was determined . The data are presented as the mean num-
ber of total cells invading per square cm at day 3 of the assay (per-
formed in duplicate gels), plus or minus the standard errors of the
means .
DEAE-HPLC-purified CSPG was digested with chondroitinase ABC (Sei-
kagaku America Inc ., Rockville, MD) and electrophoresed on 7.5 or 10%
SDS-PAGE, under reducing conditions as described previously (McCarthy
et al ., 1988x) . After electrophoresis, proteins were transferred onto nitro-
cellulose (Micron Separations Inc ., Westboro, MA) in a transfer chamber
over 2-3 h at 70 V in 0.025 M Tris and 0.192 M glycine (Towbin et al .,
1979) . The transfer of proteins was monitored by including prestained pro-
tein molecular weight standards (Amersham Corp ., Arlington Heights, IL)
on each gel . After transferring, the blot was placed in a blocking solution
for 2 h at 25°C consisting of TBS (20 mM Tris, 0.5 M NaCI), 5 % blotto,
and 1% normal goat serum . The transfer was incubated for 2 h at 25°C,
then washed for 20 min in TTBS (TBS, 0.2% TWEEN 20) . The transfers
were probed for 2 h in TTBS, 1% blotto at 25°C with a rabbit polyclonal
antibody that recognizes the unsaturated uronic acid residues that remain
attached to thePG coreprotein after chondroitinaseABC digestion (Couch-
man et al ., 1985) . Duplicate blots were probed with rat anti-CD44 mAbs,
IM7 (Picker et al ., 1989) (kindly provided by Dr. Eugene Butcher), KM81,
KM114, KM201, and KM703 (Miyake et al ., 1990) (kindly provided by
Dr. Paul Kincade) . Antibodies against the human melanoma proteoglycan
(MPG) were also tested, including mAb 9 .2.27 (Bumol et al ., 1984) and
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a rabbit polyclonal antibody, RaMPG (Spiro et al ., 1988) (kindly provided
by Dr . Robert Spiro) . As controls, normal rat sera and an isotype matched
rat anti-a4 integrin antibody, P s/2 (provided by Dr. Paul Kincade) were
used. After two 10-min washes in TTBS, goat antirabbit-, antirat- or anti-
mouse peroxidase conjugate (Organon Tecknika Corp ., West Chester, PA)
was bound in TTBS, 1% blotto for 1 h at 25°C . Blots were washed twice
in TTBS and then once in TBS for 10 min each wash . Membranes were
then developed in 100 ml enzyme/substrate buffer (TBS, 25 mg 3,3'DAB
tetrahydrochloride, 20 pl H202) until signal/noise ratio was at desired
level . The reaction was stopped by rinsing blots with water.
Results
Cell SurfaceChondroitin Sulfate Proteoglycans Play a
Role inMelanoma Cell Motility andInvasion
Three-dimensional gels composed of type I collagen were
used to monitor melanoma cell invasion . Approximately
77% of highly metastatic mouse melanoma cells applied to
each invasion gel invaded these structures to a maximum
level of 100 lAm by the third day of incubation . Of the total
cells that invaded these gels, -30% penetrated to the first
level (20 ltm), while the remaining levels contained progres-
sively decreasing numbers ofmelanoma cells (Fig . l a, solid
bars) . To evaluate the potential role of CSPGs in mediating
invasive behavior, melanoma cell invasion was observed in
the presence of increasing concentrations of ß-D-xyloside.
Melanoma cell invasion was inhibited by ß-D-xyloside in a
concentration-dependent fashion (Fig . lb), with -80% in-
hibition observed at the highest concentration of ß-D-xylo-
side tested (1.0 mM) . The number of cells detected at each
level of the invasion gel was drastically reduced in the pres-
ence of 1.0MM ß-D-xyloside (Fig . la, dottedbars) . No inhi-
bition was observed in the presence ofa-D-xyloside (Fig . la,
cross-hatched bars), an inactive analogue of ,ß-D-xyloside
that does not interfere withCSPG synthesis (Robinson et al .,
1975) . The inhibitory effects of ß-D-xyloside were predomi-
nantly at the level of entry of these cells into the gels, since
the depth of the furthest moving cells in the presence of
ß-D-xyloside was relatively unaltered compared to untreated
cells.
To determine whether or not ß-D-xyloside was cytotoxic,
melanoma cells in culture were preincubated with 1.0mM
ß-D-xyloside for 48 h, released and seeded onto the gels in
the absence of additional ß-D-xyloside . The number of cells
invading per cm2 was not significantly different for cells
pretreated with ß-D-xyloside (3,431 t 138) as for cells that
had not been exposed to this drug (4,052 t 500) . Further-
more, regardless ofß-D-xyloside treatment, cells were deter-
mined to be 95% viable by trypan blue exclusion and protein
synthesis was not affected (data not shown) . Collectively,
these results indicate that ß-D-xyloside-mediated inhibition
ofmelanoma cell invasion is reversible and not due to a cyto-
toxic effect of the drug .
To further evaluate the role of cell surface CSPG in mela-
noma cell invasion, the effects of ß-D-xyloside on melanoma
cell motility were examined in Boyden chamber type migra-
tion assays. Melanoma cell motility in response to type I col-
lagen or fibronectin was inhibited by 50% in the presence of
1.0MM ß-D-xyloside (Fig . 2 a) and not affected by the inac-
tive analogue, a-D-xyloside (data not shown) . In contrast,
ß-D-xyloside did not affect melanoma cell adhesion to type I
collagen- or fibronectin-coated substrata (Fig. 2 b) . Also, by
directly measuring the cytoplasmic area ofadherent cells, we
524Figure 2. /3-D-Xyloside inhibits melanoma cell migration, but not
adhesion or spreading on adhesion promoting proteins of the ex-
tracellular matrix . Mouse melanoma cells were pretreated for 48 h
without (solid bars) or with 1 MM ß-D-xyloside (cross hatched
bars) . (A) Cellswere examined for the ability to migrate in the Boy-
den Chamber Assay in response to 1 jug/ml of type I collagen or
fibronectin. (B) Cells radiolabeled with 'H-thymidine for the final
18 h before the assay were released from the flask with EDTA, and
examined for the ability to adhere on substrata coated with 10
pg/ml of type I collagen or fibronectin . (C) Cell spreading on 10
Ag/ml type I collagen or fibronectin was quantitated by directly
measuring the cytoplasmic area of adherent cells. Data represent
the mean percentage oftriplicate determinations plus or minus the
standard errors of the means .
determined that ß-D-xyloside-pretreated cells spread to the
same extent on type I collagen- or fibronectin-coated sub-
strata as untreatedcounterparts (Fig . 2 c) . Thus, in thepres-
ence of ß-D-xyloside, the cells were still able to adhere and
undergo cytoskeletal reorganization, indicating that mela-
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Figure 3 . Removalofcell surfaceCSPG by chondroitinase ABC in-
hibits melanoma cell motility, but not adhesion on type I collagen
or fibronectin. Mouse melanoma cells were pretreated for 15 min
with 0 (solid bars) or0.1 U/ml chondroitinase ABC (cross hatched
bars) . (A) Cells were examined for the ability to migrate in aBoy-
den chamber assay in response to 10 hg/nil type I collagen or
fibronectin . (B) Cells radiolabeled with 3H-thymidine, were ex-
amined for the ability to adhere to substrata coated with 101g/ml
type I collagen or fibronectin .
noma cell surface CSPG is not required for these processes .
These results suggest that the inhibition of melanoma cell in-
vasion by ß-D-xyloside reflects a specific effect on cell motil-
ity in response to extracellular matrix (ECM) components
such as type I collagen and fibronectin .
To further investigate the role of melanoma cell surface
CSPG in cell motility, we measured melanoma cell motility
in Boyden chambers, after treatment with chondroitinase
ABC (Fig . 3 a) . Cell migration in the presence of chon-
droitinase ABC (0.1 U/ml) was inhibited by 90% on type I
collagen andby30% on fibronectin, suggesting an important
role forCSPG in mediating motile behavior onECM compo-
nents. Aswasobserved forß-D-xyloside pretreatment, mela-
noma cell adhesion to type I collagen andfibronectinwasnot
inhibited in thepresence of chondroitinase ABC (Fig . 3 b) .
The inhibition of motility observed in the presence of chon-
droitinase ABC was attributed to the action of the chon-
droitinaseABC enzyme, since proteaseswere notdetectable
in the enzyme mixture (data not shown, see Materials and
Methods) . Thus, both ß-D-xyloside andchondroitinase ABC
treatments inhibited melanoma cell motility but not cell
adhesion or spreading on type I collagen, suggesting that
CSPGmayplayarole in melanoma cell motility andinvasion
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Figure 4. Purification of detergent-extracted 35S-proteoglycans by
HPLC-DEAE chromatography. (A) 35S-proteoglycans were ex-
tracted with 1% Triton X-100 and applied to an HPLC-DEAE
column in DEAE buffer (50 mM Tris, pH 7.0, 6 M Urea, 0.2%
CHAPS, 0.1 M NaCl) and eluted with a NaCl gradient generated
by HPLC. Radioactivity was monitored for each 1-ml fraction
(open squares) and the salt gradient was monitored by conductiv-
ity measurements (solid diamonds). (B) The fractions eluting at
0.38 M NaCl (Fig. 4 A) were pooled (as indicated by the bar) and
rechromatographed on the same column to insure maximum purity
priorto further characterization.
at the level of cellular translocation, rather than as a primary
cell adhesion receptor.
ß-DXylosideAlters CSPGProductionbyHighly
Metastatic Melanoma Cells
Considering our results indicating a role for cell surface
CSPG in mediating melanoma cell motility and invasion,
PGs synthesized by mouse melanoma cellswere isolated and
partially characterized. PGs may be associated with an ad-
herent cell as integral or peripheral membrane components,
or they may be deposited into the ECM (Hook et al., 1984;
Yanagashita and Hascall, 1984). We followed an extraction
protocol to preferentially isolate cell surface integral mem-
brane components (Yanagashita et al., 1987). Approxi-
mately 20% of the 35S-PG could be extracted by treatment
ofthe cell cultures with low levels ofheparin (50 pg/ml), in-
dicating that these molecules were noncovalently associated
with the plasma membrane or the ECM (Hook et al., 1984) .
The majority (65%) of the 35S-PGs were extracted with
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Figure 5. Elution of DEAE-purified CSPG on Sepharose CL-6B
columns. Detergent-extracted CSPG, purified by ion exchange
chromatography, was chromatographed on a Sepharose CL-6B
column in the presence of0.2 % CHAPS bothbefore (open squares)
and after (solid diamonds) release of 35S-GAGS by alkaline ß-elim-
ination. Radioactivity was monitored by liquid scintillation for each
1.0-2 .0 ml fraction. K,'s were determined by elution relative to
rat chondrosarcoma chondroitin sulfate proteoglycan and glucu-
ronolactone used to mark the column void and total volumes, re-
spectively (see Materials and Methods). The eluting material (solid
diamonds) was pooled and presence of chondroitin sulfate was
verified by nitrous acid resistance and chondroitinase ABC sensi-
tivity.
nonionic detergent, comprising those macromolecules in-
trinsically associated with the cell surface or with intracel-
lular compartments. The remaining 15% of 35S-PGs were
detergent insoluble and required guanidine-HCI for solubil-
ization, suggesting that they were associated with the deter-
gent-resistant cytoskeleton or ECM.
To further characterize melanoma cell surface CSPG, de-
tergent extracts of 3IS04-labeled melanoma cell cultures
were purified twice by HPLC-DEAE column chromatogra-
phy. The initial chromatograph of this extract contained
three partially resolved peaks as shown in Fig. 4 a. These
peaks were pooled and rechromatographed on HPLC-
DEAE, as shown for the material eluting at 0.38 M NaCl
(Fig. 4 b) . 35S-CSPG eluted exclusively at 0.38 M and con-
sisted of 85-90% chondroitin sulfate, as determined by sen-
sitivity to chondroitinase ABC and resistance to nitrous
acid. The remaining two peaks contained 35S-glycoproteins
(0.21 M) or 35S-HSPGs (0.32 M) and were not further
characterized in these studies.
HPLC-DEAE-purified CSPG accounted for 48 % of the
totaldetergent-extracted PG and contained exclusively chon-
droitin-4-sulfate, determined by descending paper chroma-
tography, with no iduronate modifications, as indicated by
>95 % sensitivity of nitrous acid-resistant molecules to
either chondroitinase ABC or AC. 35S-CSPG eluted from
a Sepharose CL-6B column between K,, 0-0.2 (Fig. 5) .
35S-Chondroitin sulfate was released from the PG by alka-
line borohydride treatment. This treatment shifted the elu-
tion volume from a Sepharose CL-6B column to a K,, of
0.55 (Fig. 5), confirming that the 35S-radiolabel was incor-
porated into O-linked carbohydrates.
The proportion of 355-PG in detergent extracts of cells
treated with ß-D-Xyloside was similar (i.e., 65 %) to that ob-
tained from untreated cell cultures, as determined by theA
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Figure 6. ß-D-xyloside alters size distribution ofdetergent-extracted
35S-labeled macromolecules. Detergent-extracted 35S-proteogly-
cans were suspended in CL-6B buffer (0.5 M sodium acetate con-
taining 0.2% CHAPS, pH 7.0) and applied to a 0.9 x 110 cm Seph-
arose CL-6B column. The CL-6B elution profiles are shown of
35S-labeled macromolecules from detergent-extracts of melanoma
cells cultured in the absence (A) or presence (B) of 1.0 MM ß-D-
xyloside. The eluting peaks werepooled and analyzed for GAG type
by nitrous acid or chondroitinase ABC digestions as described in
Materials and Methods.
amount of radioactivity recovered in detergent extracts on a
per cell basis (data not shown). However, the hydrodynamic
properties of DEAE-purified PG from detergent extracts of
melanoma cells treated with or without 1 MM ß-D-xyloside
were markedly different. Detergent-extracted "S-PG from
untreated ortreated cell cultures were batch eluted on DEAE,
pooled, andcompared by Sepharose CL-6Bchromatography.
"S-PG from untreated cells eluted from a Sepharose CL-
6B column as two partially overlapping peaks at K., 0 and
0.2, containing a mixture of CSPG and HSPG (Fig. 6 a). In
contrast, for PG isolated from ß-D-xyloside-treated cell cul-
tures, the 35S-macromolecules eluting at K., 0-0.2 contained
HSPG, determined by 95 % nitrous acid sensitivity, whereas
chondroitin sulfate eluted at K., 0.6 (Fig. 6 b) . Alkaline
borohydride treatment of ß-D-xyloside-initiated chondroitin
sulfate did not alter the K,, of the eluting material on a
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Detergent-extracted CSPG Produced by
Melanoma Cells Binds to Type I Collagen and Has
Properties Consistent with Plasma
Membrane Intercalation
z
Figure 7 . 35S-CSPG binds to a type I collagen affinity column. (A)
Detergent-extracted HPLC-DEAE purified 35S-CSPG or (B) alka-
line borohydride-released, nitrous acid-resistant chondroitin sul-
fate was applied to a type I collagen affinity column (0.175 mg/ml)
in 50 mM Tris, pH 6.8, 50 mM NaCl, 0.5 % CHAPS and eluted with
a NaCl gradient. Radioactivity was monitored for each 2-3-ml
fraction (open squares) and the salt gradient was monitored by con-
ductivity measurements (solid diamonds) .
Sepharose CL-6B column (not shown), confirming that the
chondroitin sulfate synthesis in the ß-D-xyloside-treatedcul-
tures was uncoupled from core protein synthesis. Further-
more, the amount of nitrous acid-sensitive 35S-proteogly-
cans recovered from unfractionated cell extracts of either
culture condition differed by <10% (data not shown), sug-
gesting that HSPG synthesis was not altered in the presence
ofß-D-xyloside. These results demonstrate that 1.0 MM ß-D-
xyloside effectively uncoupled chondroitin sulfate synthesis
from the core protein, while the attachmentof heparan sul-
fate to the core protein was essentially uninterrupted.
The above results strongly support a role for melanoma cellN
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Figure 8. Detergent-extracted murinemelanoma CSPG binds Octyl
Sepharose. (A) HPLC-DEAE-purified 35S-CSPG was resuspended
in Octyl Sepharose buffer (4.0 M Guanidine HCL, 20 mM Tris, pH
6.8) and applied to a 5-ml Octyl Sepharose column at a flow rate
of 0.5 ml/min. Hydrophobic CSPG were then eluted with a linear
gradient of Triton X-100 from 0 to 0.5 % in Octyl Sepharose buffer.
Fractions of 2 ml each were analyzed for 35S radioactivity (open
squares) by liquid scintillation and percent Triton X-100 by ab-
sorbance at 280 not (solid diamonds) . (B) HPLC-DEAE-purified
35S-CSPG was briefly digested with trypsin before Octyl Sepha-
rose chromatography.
surface CSPG in type I collagen-mediated melanoma cell
motility and invasion. By utilizing a solid phase binding as-
say, containing type I collagen coated onto microtiter wells,
we determined that DEAE-HPLC-purified CSPG bound to
type I collagen in a concentration dependent and saturable
fashion (data not shown). HPLC-DEAE-purified CSPG also
bound to a type I collagen affinity column in the presence
of 0.5% CHAPS and was eluted from the column by 0.4 M
NaCI (Fig. 7 a). The binding of 35S CSPG was specific to
type I collagen since it failed to bind to an affinity column
prepared without type I collagen. To further evaluate the
mechanism by which CSPG bound to type I collagen, chon-
droitin sulfate released from the protein core by alkaline
ß-elimination and treated with nitrous acid to remove any
contaminating heparan sulfate, was applied to the type I col-
lagenaffinity column. The nitrous acid-resistant chondroitin
sulfate bound to the type I collagen affinity column and
eluted as a broad peak with 0.1-0.4 M NaCl (Fig. 7 b), which
was much more heterogenous that that observed for intact
CSPG. These studies demonstrate that mouse melanoma cell
surface CSPG binds directly to type I collagen and that this
interaction is mediated, at least in part, by chondroitin
sulfate.
Hydrophobic chromatography has been used by other in-
vestigators to identify potential intercalated cell surface pro-
teoglycans (Yanagashita et al., 1987) . Approximately 80%
of detergent-extracted HPLC-DEAE-purified "S-CSPG
bound to an Octyl Sepharose column and was eluted with
concentrations ofTriton-X-100 that were close to the critical
micellar concentration of this detergent (Fig. 8 a). In con-
trast, detergent-extracted CSPG that had been treated briefly
with low levels of trypsin failed to bind this column (Fig. 8
b). These results are consistent with the hypothesis that a hy-
drophobic domain within the detergent-extracted CSPG pro-
tein core mediates binding to the hydrophobic column. Im-
portantly, "S-chondroitin sulfate macromolecules isolated
from ß-D-xyloside cultures also failed to bind this column
(not shown), further demonstrating that ß-D-xyloside treat-
ment prevents the expression of intact cell surface CSPG in
mouse melanoma cells.
To determine the apparent molecular weight of the mouse
melanoma CSPG core protein, detergent-extracted, HPLC-
purified'z5I-labeled CSPG was digested with chondroitinase
ABC and analyzed by 6-15% SDS gel electrophoresis under
nonreducing conditions (Fig. 9, lane A). A single CSPG core
protein was observed at -110 kD by autoradiography, with
a slight but noticeable increase in molecular mass observed
upon reduction of this protein (not shown). No radioactivity
was observed in lanes that contained heparatinase-digested
"'l-CSPG (Fig. 9, lane B), undigested "'I-CSPG (Fig. 9,
lane C), or chondroitinase ABC (Fig. 9, lane D). To confirm
that the 110-kD band was a core protein of CSPG, chondroi-
tinase digests of melanoma CSPG from similar gels were
electroblotted onto nitrocellulose and probed with a poly-
clonal antibody that recognizes the unsaturated bonds of
chondroitin sulfate-associated uronic acid residues that re-
main after chondroitinase ABC digestion (Couchman et al .,
1985) . Such blots indicate a single band at -110 kD specifi-
cally detected by the antibody (Fig. 10 A, lane 2) . The speci-
ficity ofthereaction is indicated by the failureofthis antibody
to recognize undigested CSPG (Fig. 10 A, lane 1) or chon-
droitinase ABC (Fig. 10 A, lane 3).
The relationship of mouse melanoma CSPG to other pre-
viously described cell surface PGs was evaluated by probing
duplicate Western blots with antibodies against the human
melanoma proteoglycan that has a 250-kD core protein (Bumol
et al., 1984) and CD44, an 80-95-kD glycoprotein that may
contain chondroitin sulfate modifications (Jalkanen et al.,
1988 ; Brown et al., 1991). IM7, an anti-CD44 mAb (Picker
et al., 1989) recognizes a single band at -110 kD in the lane
containing chondroitinase-digested CSPG (Fig. 10 B, lane
4), suggesting that murine melanoma CSPG is immunologi-
cally related to CD44. No immunological reactivity was ob-
served in lanes containing undigested CSPG (Fig. 10 B, lane
5) or chondroitinase ABC (Fig. 10 B, lane 6). Similar results
were obtained with four additional mAbs, KM81, KM114,
KM201, and KM703, that detect different epitopes on CD44
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Figure 9 . Identification of 110-
kD core protein ofmouse mela-
noma CSPG by autoradiogra-
phy. 125I-labeledDEAE-HPLC
purified CSPG was digested
with chondroitinase ABC and
analyzedby 6-15% SDS-PAGE
undernonreducingconditions .
(Lane A) chondroitinaseABC
digestedCSPG ; (B) heparatin-
ase digested CSPG ; (C) undi-
gested CSPG ; (D) chondroi-
tinaseABC.
(Miyake et al ., 1990 [data not shown]) . Chondroitinase-
digested CSPG was not recognized by antibodies against
MPG, monoclonal 9.2.27 (Bumol et al ., 1984) or polyclonal
RotMPG (Spiro et al ., 1988) or by preimmune rat sera or rat
anti-a4 integrin antibody, P s/2 (data not shown) . These
results indicate that the 110-kD core protein ofmouse mela-
nomaCSPG is immunologically related to CD44, but not to
the 250-kD CSPG core protein identified on human mela-
noma cells .
Our studies demonstrate an important role for a cell surface
CD44-related CSPG in mouse melanoma cell motility and
invasion into type I collagen matrices . By pharmacologically
blocking mouse melanoma cell production of CSPG with
ß-D-xyloside, we observed a corresponding decrease in
melanoma cell migration and invasive behavior on type I col-
Figure 10 . Mouse melanoma cells express a 110413 CD44-related
CSPG core protein . Detergent-extracted, DEAE-HPLC-purified
CSPG was digested with chondroitinaseABC and electrophoresed
under (A) reducingconditionson 7.5% SDS-PAGE or (B) nonreduc-
ingconditions on 10% SDS-PAGE . Proteins on thesegels weretrans-
ferred to nitrocellulose and probed with (A) a polyclonal antibody
that recognizes the unsaturated bonds ofchondroitin sulfate-associ-
ated uronic acid residues that remain after chondroitinase ABC di-
gestion (Couchman et al ., 1985)or (B)IM7, a ratmAbagainstCD44
(Picker et al ., 1989) . (Lanes 1 and S) undigested CSPG ; (2 and 4)
chondroitinase-digested CSPG; (3 and 6) chondroitinase ABC.
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lagen . Melanoma cell motility on type I collagen could also
be inhibited by enzymatically removing cell surface chon-
droitin sulfate with chondroitinase ABC. In contrast, type I
collagen-mediated cell adhesion and spreading were not af-
fected by either ß-D-xyloside or chondroitinase treatments .
Purified mouse melanoma cell surface CSPG was shown to
bind to type I collagen and to have properties consistent with
localization as an integral plasma membrane component .
Furthermore, we have identified a mouse melanoma CSPG
with a 110-kD core protein that is recognized by antibodies
againstCD44 on Western blots, but not by antibodies against
the 250-kD CSPG core protein identified on human mela-
noma cells . Collectively, our data suggests that mouse mela-
noma cell surface CSPG may interact with type I collagen
of the ECM and subsequently mediate melanoma cell motil-
ity and invasion within three dimensional collagen gels in
vitro.
Several lines of evidence from other investigators support
the hypothesis that cell surface CSPG contributes to the mo-
tile behavior of normal and transformed cells . Wounded en-
dothelial cell cultures have been observed to rapidly change
proteoglycan production from heparan sulfate to chondroitin
sulfate coincident with the onset of motility (Kinsella and
Wight, 1986) . CSPGs have also been implicated in regulat-
ing the migration ofcardiac mesenchymal cells (Funderburg
and Markwald, 1986) and neural crest cells (Perris and John-
son, 1987) . Furthermore, human melanomaCSPG has been
localized to microspikes, a cell surface microdomain (Gar-
rigues et al ., 1986), and has been implicated to play a role
in human melanoma cell adhesion and metastatic behavior
(Bumol et al ., 1984) . Despite the widely recognized rela-
tionship betweenCSPG and cell motility, the precise mecha-
nism through which CSPG mediates cell motility is not yet
understood .
Cell surfaceCSPG does not appear to be a primary mela-
noma cell adhesion receptor for type I collagen, since cell
adhesion and spreading on type I collagen were unaffected
by ,ß-D-xyloside or chondroitinase ABC treatments . Other
cell surface receptors that may mediate the adhesion of mov-
ing cells include integrins, the major family of receptors
known to mediate cell adhesion (Ruoslahti and Piersch-
bacher, 1987 ; Albelda and Buck, 1990 ; Humphries, 1990) .
Cell surface HSPGs have also been shown to mediate cell at-
tachment to ECM proteins (Lark et al ., 1985 ; LeBaron
et al ., 1988 ; McCarthy et al ., 1986 ; Woods et al ., 1986 ;
Rogers et al ., 1987 ; Saunders and Bemfield, 1988) . HSPGs
have been associated with newly formed adhesions of adher-
ent cells (Lark et al ., 1985), while older focal adhesions,
found at the trailing edge of a moving cell, are primarily
composed of CSPG (Culp et al ., 1978) . While certain cell
surface HSPGs and integrinsmay be involved in cell motility
by promoting cell adhesion and spreading at the leading edge
of a moving cell, our data is consistent with the hypothesis
that cell surface CSPG may disrupt these adhesive contacts
and promote the release ofthe trailing edge ofa moving cell,
as has been previously proposed by Culp et al . (1978) .
The molecular mechanism by which mouse melanoma
CSPG modulates cell adhesion during cell motility has not
been clearly defined . Several studies have indicated that
CSPG, isolated from a wide variety of sources, exerts an-
tagonistic effects on cell adhesion to ECM proteins such as
fibronectin, collagen, and laminin (Knox and Wells, 1979 ;
529Rich et al., 1981; Brennan et al ., 1983 ; Rosenberg et al.,
1985 ; Yamagata et al., 1989). CSPG may interfere with cell
attachment either by competing with other cell surface
receptors for binding to ECM molecules at the GAG binding
sitesand/or by masking the integrin binding sites (Ruoslahti,
1988). By weakening cell adhesion to other ECM compo-
nents, CSPG may participate in cell motility by facilitating
cell detachment (Culpet al., 1986; Ruoslahti, 1988). In this
regard, the ability of CS on the surface of melanoma cells
to bind type I collagen may be important for bringing cell
surface CSPG into a close association with other adhesion
receptors such as integrins. The close proximity of cell sur-
face CSPG to other cell adhesion receptors may serve to
disrupt the association of receptors at that site of the cell
membrane and subsequently alter the adhesive contacts. Al-
ternatively, mouse melanoma CSPG could serve to transmit
additional signals to the interior of the cell, thereby indirectly
modulating cell adhesion and migration (Yamagata et al.,
1989) . Further study of the molecular and cellular basis of
cell surface CSPG interactions with ECM components will
be required to understand the role of cell surface CSPG in
melanoma cell motility and invasion.
In addition to demonstrating an immunological relation-
ship, the structural and functional properties ofmouse mela-
noma CSPG are similar to CD44, a cell surface molecule
that hasbeen implicated in mediating cell-cell and cell-ECM
interactions (Gallatin et al., 1989; Haynes et al., 1989; Jal-
kanen et al., 1988; Miyake et al., 1990) . Although the 110-
kD core protein of mouse melanoma CSPG is slightly larger
than the well characterized 80-95-kD CD44 glycoprotein,
larger forms ofCD44 have recently been identified that have
various carbohydrate modifications, such as CS addition
(Jalkanen et al., 1988; Brown et al., 1991), or result from
alternative splicing of mRNA coding for CD44 (Brown et
al., 1991; Günthert et al., 1991). The class III ECM receptor
(ECMRIII [Wayner and Carter, 1987]), recently identifiedas
CD44 (Gallatin et al., 1989), has been shown to bind to col-
lagen, although it does not directly mediate cell adhesion
(Wayner, 1987), similarto thefunctional properties currently
identified for mouse melanoma CSPG. Furthermore, CD44
has been shownto be associated with thecytoskeleton (Jacob-
son et al., 1984; Kalomiris and Bourguignon, 1988) and to
play a role in cell movement (Jacobson et al ., 1984) . Impor-
tantly, a variant form of CD44, containing an additional ex-
tracellular domain, has recently been implicated in mediat-
ing the metastatic behavior ofcertain rat carcinoma cell lines
(Günthert et al., 1991) . Additional studies that further define
the structural similarities of the mouse melanoma CSPG
core protein and CD44, as well as studies of this particular
CSPG in low metastatic counterparts of the K1735 mela-
noma and normal melanocytes, will help to elucidate the
mechanism by which mouse melanoma CSPG mediates tu-
mor cell motility and invasion.
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